EMOGLOBINURIA PAROSSISTICA NOTTURNA PDF

emoglobinuria parossistica notturna (enp) sindrome di marchiafava-micheli dati epidemiologici la patologia puo presentarsi qualsiasi eta anche se si presenta. In medicina l’anemia emolitica microangiopatica, in inglese Microangiopathic Haemolytic altre malattie: eclampsia, rigetto dell’allotrapianto renale, emoglobinuria parossistica notturna, sclerodermia e vasculiti come poliarterite nodosa e. Trattamento dell’emoglobinuria parossistica notturna. Latvian. Ekulizumabs. Paroksismālas nakts hemoglobinūrijas ārstēšana. Lithuanian. Ekulizumabas.

Author: Darisar Shat
Country: Montenegro
Language: English (Spanish)
Genre: Science
Published (Last): 8 October 2008
Pages: 150
PDF File Size: 20.10 Mb
ePub File Size: 13.92 Mb
ISBN: 768-5-77449-552-1
Downloads: 49513
Price: Free* [*Free Regsitration Required]
Uploader: Shazragore

Biochimica Clinica ; 37 4 Documenti – Documents. Biochimica Clinica ; 37 4 Editoriale – Editorial. Proposal of a checklist for venous blood collection.

SIBioC Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica ()

Si prega di fare riferimento alla sezione 4. In altri progetti Wikimedia Commons.

Click here if you do not remember your login details Emoglobinurria Back. Expenditure control in clinical laboratories: Approssimativamente 6 mesi per la Parte 1; approssimativamente 8 mesi per le Parti 2 e 3.

Visite Leggi Modifica Modifica wikitesto Cronologia. Anemia emolitica microangiopatica all’ esame microscopico. Valutazione preliminare del sistema Alere NS-Plus per la determinazione della transferrina fecale. Paroxysmal Nocturnal Hemoglobinuria is a rare, acquired, life-threatening disease of the blood that leads to the premature death and impaired production of red blood cells.

  MALY KSIAZE PDF

A disposizione per ulteriori informazioni. Proporzione di pazienti con livelli stabilizzati di emoglobina 4. Total and target engaged C5 concentration 5.

Safety and PD Parts 1, 2, and 3: Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial.

I risultanti schistociti sono fortemente captati per la loro distruzione dal sistema reticoloendoteliale nella milza, a causa dei loro stretti passaggi attraverso i lumi dei vasi ostruiti. Biochimica Clinica ; 37 4 Rassegne – Reviews. Click here if you do not remember your login details. Follow these steps to login: If you already own username and password, you can proceed with your registration to the event. Both Female Only Male Only. Trials with results Trials without results. Methodological notes on acquisition and use of close evacuated systems for collection, handling and storage of venous blood samples for laboratory diagnostics.

Change in free-haemoglobin 3. It is aimed at reviewing: Paroxysmal nocturnal hemoglobinuria PNH. IMP with orphan designation in the indication. Cambiamento della condizione di affaticamento misurata tramite il functional assessment of chronic illness therapy FACIT fatigue 5.

Biochimica Clinica: VOL.37 N.4

Menu di navigazione Strumenti personali Accesso non effettuato discussioni contributi registrati entra. The IMP has been designated in this indication as an orphan drug paossistica the Community.

  DBX DRIVERACK 480 PDF

Pour les utilisateurs individuels: Incidence of dose-limiting events 2. In ricordo di Renzo Galanello. The total CV was 7. Efficacy Parts 2 and 3: The athlete biological passport.

Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Vedi le condizioni d’uso per i dettagli. Reducing stress shear may decrease hemolysis associated to intravenous catheter blood collection. Vous devez vous identifier: EU Clinical Trials Register.

Please see section 4. Safety Parts 1, 2, and 3: Parti 1, 2 e 3: For this reason it is important that you indicate a valid email address. Altri progetti Wikimedia Commons. Pneumonia AND sponsor name. To access the requested page you need to enter username and password in “Area Soci”. Le informazioni riportate non sono consigli medici e potrebbero non essere accurate. Proportion of patients with complement suppression throughout the dosing interval PK Parts 1, 2, and 3: